Brain–computer interface technology is enabling children with physical disabilities to play video games with their minds - University of Calgary

Precision Neuroscience has raised $250 million in an oversubscribed Series D financing, bringing its total funding to $430 million as it advances its brain-computer interface technology toward broader clinical use and commercialization. The round was co-led by Pershing Square Inc., the Ackman Oxman Institute, and an undisclosed life sciences investment fund. Additional investors included Duquesne Family Office, B Capital, ARK Invest, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, and JSL Health Capital. Founded in 2021, Precision develops brain-computer interface technology intended to establish a communication pathway between the human brain and external computing systems.